Literature DB >> 23090770

Leukocyte-dependent responses of the microvasculature to chronic angiotensin II exposure.

Alper Yildirim1, Janice Russell, Li-Sue S Yan, Elena Y Senchenkova, D Neil Granger.   

Abstract

Angiotensin II (Ang II) contributes to the pathogenesis of hypertension and other cardiovascular diseases. Ang II induces a pro-oxidative, proinflammatory, and prothrombogenic phenotype in vascular endothelial cells. Although the peptide promotes the recruitment of leukocytes and platelets and induces oxidative stress in the microvasculature, it remains unclear whether and how the blood cell recruitment is linked to the production of reactive oxygen species. In this study, we addressed the contributions of Ang II type 1 receptors (AT(1)r) and gp91(phox) to the recruitment of leukocytes and platelets and reactive oxygen species production in venules during chronic (2-week) infusion of Ang II in wild-type (WT) and mutant mice. Intravital video microscopy was used to measure the adhesion and emigration of leukocytes, the adhesion of fluorescently labeled platelets, and dihydrorhodamine oxidation (a measure of oxidative stress) in cremaster muscle postcapillary venules. In WT mice, Ang II infusion induced a time-dependent increase in the adhesion of leukocytes and platelets and enhanced reactive oxygen species production in venules. These changes in blood cell adhesion and reactive oxygen species production were not observed in AT(1)r(-/-) mice, AT(1)r(-/-) bone marrow chimeras (blood cells deficient in AT(1)r), gp91(phox-/-) mice, gp91(phox-/-) chimeras (blood cells or endothelial cells deficient in gp91(phox)), and in WT mice rendered granulocytopenic via intraperitoneal injection of antimouse granulocyte receptor 1 antibody. Thrombocytopenic WT mice (platelets depleted by intraperitoneal injection of rabbit antimouse thrombocyte antiserum) responded similar to WT mice. These findings implicate leukocyte-associated AT(1)r and gp91(phox) in the induction of the pro-oxidative, proinflammatory, and prothrombogenic phenotype assumed by microvessels that is chronically exposed to elevated Ang II.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23090770      PMCID: PMC3499636          DOI: 10.1161/HYPERTENSIONAHA.112.198465

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  31 in total

1.  NAD(P)H oxidase-derived superoxide mediates hypercholesterolemia-induced leukocyte-endothelial cell adhesion.

Authors:  K Y Stokes; E C Clanton; J M Russell; C R Ross; D N Granger
Journal:  Circ Res       Date:  2001-03-16       Impact factor: 17.367

2.  Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways.

Authors:  R M Touyz; E L Schiffrin
Journal:  J Hypertens       Date:  2001-07       Impact factor: 4.844

Review 3.  Role of blood cells in ischaemia-reperfusion induced endothelial barrier failure.

Authors:  Stephen F Rodrigues; D Neil Granger
Journal:  Cardiovasc Res       Date:  2010-03-17       Impact factor: 10.787

Review 4.  The role of oxidative stress in the pathophysiology of hypertension.

Authors:  Ramón Rodrigo; Jaime González; Fabio Paoletto
Journal:  Hypertens Res       Date:  2011-01-13       Impact factor: 3.872

Review 5.  Reactive oxygen species and vascular biology: implications in human hypertension.

Authors:  Rhian M Touyz; Ana M Briones
Journal:  Hypertens Res       Date:  2010-10-28       Impact factor: 3.872

6.  Angiotensin II induces leukocyte-endothelial cell interactions in vivo via AT(1) and AT(2) receptor-mediated P-selectin upregulation.

Authors:  L Piqueras; P Kubes; A Alvarez; E O'Connor; A C Issekutz; J V Esplugues; M J Sanz
Journal:  Circulation       Date:  2000-10-24       Impact factor: 29.690

7.  Hypercholesterolemia promotes P-selectin-dependent platelet-endothelial cell adhesion in postcapillary venules.

Authors:  Anitaben Tailor; D Neil Granger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-16       Impact factor: 8.311

Review 8.  The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases.

Authors:  Hua Cai; Kathy K Griendling; David G Harrison
Journal:  Trends Pharmacol Sci       Date:  2003-09       Impact factor: 14.819

9.  Role of interferon-gamma in hypercholesterolemia-induced leukocyte-endothelial cell adhesion.

Authors:  Karen Y Stokes; E Chris Clanton; Kris P Clements; D Neil Granger
Journal:  Circulation       Date:  2003-04-14       Impact factor: 29.690

Review 10.  Angiotensin II revisited: new roles in inflammation, immunology and aging.

Authors:  Ariela Benigni; Paola Cassis; Giuseppe Remuzzi
Journal:  EMBO Mol Med       Date:  2010-07       Impact factor: 12.137

View more
  5 in total

1.  Novel Role of T Cells and IL-6 (Interleukin-6) in Angiotensin II-Induced Microvascular Dysfunction.

Authors:  Elena Y Senchenkova; Janice Russell; Alper Yildirim; D Neil Granger; Felicity N E Gavins
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

2.  Formyl-Peptide Receptor 2/3/Lipoxin A4 Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease.

Authors:  Shantel A Vital; Felix Becker; Paul M Holloway; Janice Russell; Mauro Perretti; D Neil Granger; Felicity N E Gavins
Journal:  Circulation       Date:  2016-05-06       Impact factor: 29.690

3.  Monocytes are recruited from venules during arteriogenesis in the murine spinotrapezius ligation model.

Authors:  Anthony C Bruce; Molly R Kelly-Goss; Joshua L Heuslein; Joshua K Meisner; Richard J Price; Shayn M Peirce
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-06-26       Impact factor: 8.311

4.  Hypercholesterolemia blunts the oxidative stress elicited by hypertension in venules through angiotensin II type-2 receptors.

Authors:  Alper Yildirim; Elena Senchenkova; D Neil Granger
Journal:  Microvasc Res       Date:  2016-01-14       Impact factor: 3.514

Review 5.  Novel Immune Mechanisms in Hypertension and Cardiovascular Risk.

Authors:  Ryszard Nosalski; Eilidh McGinnigle; Mateusz Siedlinski; Tomasz J Guzik
Journal:  Curr Cardiovasc Risk Rep       Date:  2017-03-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.